Filter
2962
Filtered Results: 2962
Text search:
drug
market
Featured
Recommendations
259
New Publications
814
Language
Document type
No document type
1710
Studies & Reports
504
Guidelines
384
Manuals
141
Strategic & Response Plan
119
Training Material
39
Fact sheets
38
Situation Updates
10
Resource Platforms
8
Infographics
6
Brochures
1
App
1
Online Courses
1
Countries / Regions
India
196
Global
119
Kenya
99
Uganda
82
Ethiopia
81
Nigeria
67
South Africa
65
Western and Central Europe
60
Ghana
51
Sierra Leone
49
Bangladesh
48
Liberia
48
Malawi
47
Tanzania
47
Nepal
46
Myanmar / Burma
46
Zambia
43
Rwanda
38
Africa
38
Latin America and the Carribbean
36
Namibia
34
South–East Asia Region
31
Philippines
30
Zimbabwe
27
Ukraine
25
Eastern Europe
22
Lesotho
21
Cambodia
21
Congo, Democratic Republic of
21
Indonesia
19
Syria
18
Asia
18
Botswana
18
Russia
15
Senegal
12
Mozambique
12
Eswatini/ Swaziland
11
Burkina Faso
10
Venezuela
10
East and Southern Africa
10
Brazil
10
USA
9
Eastern Europe and Central Asia
9
Thailand
8
Cameroon
8
Albania
8
Guinea
8
West and Central Africa
8
Middle East and North Africa
8
Georgia
8
South Sudan
8
Haiti
7
Germany
7
Laos
6
Vietnam
6
Sudan
6
Tajikistan
5
Colombia
5
China
5
North America
5
Timor Leste/ East Timor
4
Mexico
4
Western Pacific Region
4
Lebanon
4
Sri Lanka
4
Central African Republic
4
Libya
4
Iraq
4
North Macedonia
3
Benin
3
Iran
3
Peru
3
Jordan
3
Paraguay
3
Papua New Guinea
3
Moldova
3
Bhutan
3
Somalia
3
Pakistan
3
Chile
2
Fiji
2
Kyrgyzstan
2
Afghanistan
2
Morocco
2
Hungary
2
Tunisia
2
Argentina
2
Yemen
2
Palestine
2
Poland
2
Mali
2
North Korea
1
El Salvador
1
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Estonia
1
Uzbekistan
1
Qatar
1
Bulgaria
1
Italy
1
Armenia
1
Dominican Republic
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Mauritius
1
Norway
1
Portugal
1
Bolivia
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Greece
1
Honduras
1
Angola
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1216
Clinical Guidelines
243
Public Health
152
Women & Child Health
89
Key Resources
87
Pharmacy & Technologies
47
Capacity Building
36
Toolboxes
HIV
301
Mental Health
291
TB
190
AMR
177
Pharmacy
142
COVID-19
117
NTDs
101
NCDs
71
Malaria
51
Caregiver
50
Rapid Response
42
Planetary Health
40
Conflict
38
Ebola & Marburg
37
Refugee
35
Global Health Education
34
Health Financing Toolbox
31
Disability
29
Natural Hazards
13
Cholera
13
Specific Hazards
10
Social Ethics
7
Polio
7
Zika
4
The world is not on track to end the AIDS pandemic. New infections are rising and AIDS deaths are continuing in too many communities. This report reveals why: inequalities are holding us back. In frank terms, the report calls the world’s attention to the painful reality that dangerous inequalities...
Through public-private partnerships, the government of Rwanda can make more efficient use of public resources by targeting and meeting the needs of specific populations and thus help ensure family planning services and products will be available to all Rwandans in the long term. This report aims to ...
Thousands of HIV-positive Venezuelans have been forced to leave the country, after facing discrimination and zero treatment options, according to UNAIDS.
Patients once received free ARV treatment under Venezuela’s National AIDS Program. In 2017, the country essentially ran out of ARVs—about 9 p...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are ...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...
PLOS Glob Public Health 4(12): e0004035. https://doi. org/10.1371/journal.pgph.0004035.
A new formulation of praziquantel, arpraziquantel (arPZQ), has been developed for preschool-
aged children (PSAC) to fill the treatment gap for this age group in schistosomiasis control and
elimination program...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul...
Migrants and mobile popul...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
Antimicrobial resistance (AMR) both in human and veterinary medicine has reached alarming levels in
most parts of the world and has now been recognized as a significant emerging threat to global public
health and food security. In June 2015, the Food and Agriculture Organization of the United Nati...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
State of Health in the WHO African Region
recommended
This report is not a country scorecard. Rather, its purpose is to act as a compass to guide progress towards health in the SDGs.
There has been a significant improvement in the state of health in the region with healthy life expectancy - time spent in full health - in the region increasing from 50...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, and b.) there is a high prevalence of HIV infection, both known
and...
MSF Essential Drugs - Practical Guidelines 2022
recommended
Practical guide intended for physicians, pharmacists, nurses and medical auxiliaries. This guide is not a dictionary of pharmacological agents. It is a practical manual intended for health professionals, physicians, pharmacists, nurses and health auxiliaries invoved in curative care and drug managem...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T...
